Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Here’s Why

Eurofins Scient (OTCMKTS:ERFSFGet Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $74.9060, but opened at $79.78. Eurofins Scient shares last traded at $79.78, with a volume of 76 shares traded.

Analysts Set New Price Targets

ERFSF has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. BNP Paribas Exane raised Eurofins Scient to an “outperform” rating in a report on Monday, January 5th. Finally, Citigroup reaffirmed a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Read Our Latest Stock Analysis on Eurofins Scient

Eurofins Scient Stock Up 1.6%

The company has a fifty day moving average of $78.44 and a two-hundred day moving average of $74.89. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.19 and a current ratio of 1.26.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

See Also

Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.